High Impact...multi-bagger!!!!Investors looking for Big Rewards with minimal risk at this late stage of a FDA imminent approval,...needs to have a locked-in share position in PharmaTher....Hugh upside very soon.
Look to the company's latest February 2024 Presentation on their web-site. Hold and Accumulate, at these extremely low prices....All time high was $1.20/share in 2021, raised $10mm in August 2021 at .66 cents/share with warrants expiring in 2026 at .80 cents exercise price, and that will bring in more than $6mm in cash and adding in their current $4mm cash, gives them a total of $10mm to finance its marketing/Sales and distribution for its approved FDA KETRAX....NO NEED FOR ANY FINANCING!!! Preventing share dilution....great financial position ...